News

In this key senior executive position, Dr Sadek will manage the biostatistics, data management and information technology departments at New England Research Institutes (NERI). In addition to his

Mr O’Caoimh will succeed Brendan Farrell, who has resigned with immediate effect, having served as Trinity’s president since 1994 and as CEO since November 2007. Mr O’Caoimh said:

Mr Noonan’s business career spans more than 30 years including 13 years in senior management roles with Laguna Niguel, a medical and industrial polymer components manufacturer. Mr Noonan’s

Lux Biosciences has licensed the global rights to all ophthalmic indications from Isotechnika and has made an initial payment of $2 million under a commercial supply agreement previously

AbaStar MDx will utilize Gene Express’s proprietary technology in the development and commercialization of genetic biomarkers for the accurate diagnoses of neurological and psychological disorders. The combination of

In the study, trodusquemine (MSI-1436) was found to be well-tolerated and no serious adverse events were experienced at likely clinical doses. There were indications of dose-dependent weight loss

Under the contract to be performed over a five-year period, Caprion will act as one of two National Institute of Allergy and Infectious Diseases (NIAID) Clinical Proteomics Centers

The company has greatly valued Dr Zhang’s contribution as a director of the company for the past few years.

Following the FDA advisory committee vote that there was substantial evidence of efficacy of Provenge and that Provenge was reasonably safe, the FDA requested additional clinical data to